Search

everythinglearnresearchcommunity

for

Search:↓

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Patients with chronic kidney disease on hemodialysis often have skin problems.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Low ferritin and cobalamin levels are better indicators of chronic hair loss in reproductive-age women than hemoglobin levels.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Oral minoxidil effectively reduces hair shedding in women with chronic telogen effluvium.

Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

A girl with no hair neglect developed plica neuropathica in the hospital, lost all her hair, but it grew back.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Wearing a hijab does not cause hair loss.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The conclusion is that skin, mucous, and eye problems after Stevens-Johnson syndrome and Lyell syndrome significantly affect patients' lives, highlighting the need for comprehensive care and eye check-ups.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

Psychological stress and personal history are significant factors in hair loss.